Option chain shows key data for Cadrenal Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Cadrenal Therapeutics.

Cadrenal Therapeutics (NASDAQ:CVKD) Stock, Option Chain

Cadrenal Therapeutics

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

APLT

BGNE

CNEY

CSBR

CVKD

FTCI

IBRX

ISPC

NITO

NTGR

PEGY

PMNT

PTIX

RYDE

SMFL

SYRA

TBIO

Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket

Penny Stocks

Small Cap

Intraday Update

ACLS

APPS

ASTS

BETS

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BTDR

CAMP

CCTG

DYNT

EVER

GPRO

HCTI

HKIT

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

LITE

LSPD

MGRX

MLGO

MLYS

MPWR

MRDB

NVST

OSCR

PBAX

PYPL

QNST

ROMA

TENX

THMO

TRUG

UCAR

VKTX

WETG

WIMI

YTEN

ZCMD

Shares of  Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results.

Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

ATRA

BCEL

BIOR

CANO

CHEA

DCFC

FDMT

GRDI

MEGL

NEXI

NSTG

TWOU

WORX

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading.

4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability &amp; clinical activity in wet AMD.

Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics Inc

Offerings

Press Releases

Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds

CADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATE

CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS

Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook

Cadrenal Therapeutics Gears Up for the 43rd Annual J.P. Morgan Healthcare Conference Week with Event Participation and Investor/Partner Meetings

Early Santa Claus Rally Highlights Power Nickel Inc. (TSXV: PNPN) and Other Stocks to Watch Now!

Cadrenal Therapeutics Provides 2024 Year-End Company Update, Reinforcing Clinical Development Plan for Tecarfarin in LVAD and Other Rare Cardiovascular Indications

Cadrenal Therapeutics to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Cadrenal Therapeutics to Present at BIO CEO & Investor Conference

Cadrenal Therapeutics Announces Chief Medical Officer Transition to Advance Clinical Development of Tecarfarin

APCX

BPTH

ELAB

PNPNF

PRFX

RJDG

TSXV:PNPN

Anebulo Pharmaceuticals, Inc. - Common Stock

Anebulo Pharmaceuticals

AN2 Therapeutics

CalciMedica

Cara Therapeutics

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cocrystal Pharma

Dare Bioscience

Durect

Grace Therapeutics

Impact BioMedical

IGC Pharma

Opus Genetics

Iterum Therapeutics

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Lexaria Bioscience

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

NRX Pharmaceuticals

OptiNose

Pulmatrix

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience

Scilex Holding

SCYNEXIS

Verrica Pharmaceuticals Inc. - Common Stock

Verrica Pharmaceuticals

VYNE Therapeutics

HC Wainwright & Co.

Noble Capital Markets

Comments

Cadrenal Therapeutics

Cadrenal Therapeutics (CVKD) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga